HIMS earnings
Hims & Hers Health Inc. (HIMS) earnings releases and earnings dates - real-time wire coverage of every quarterly report.
Recent earnings items
- Hims & Hers Health, Inc. Reports First Quarter 2026 Financial ResultsRevenue of approximately $608 million, up 4% year-over-year in Q1 2026 Subscribers grew to nearly 2.6 million, up 9% year-over-year in Q1 2026 Raises full year 2026 revenue guidance1 to a range of $2.8 billion to $3.0 billion and updates Adjusted EBITDA guidance to a range of $275 million to $350 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2026. Moving forward, the Company plans to transition to an annual rather than quarterly shareholder letter and will continue to provide regular updates through a quarterly earnings call, earnings rele
- Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on Monday, May 11, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's management
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial ResultsRevenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 Subscribers grew to over 2.5 million, up 13% year-over-year in 2025 Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. "More than 2.5 million subscribe
- Hims & Hers to Announce Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2025 financial results after the market closes on Monday, February 23, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the c
- Hims & Hers Health, Inc. Reports Third Quarter 2025 Financial ResultsRevenue of nearly $600 million, up 49% year-over-year in Q3 2025 Net income of nearly $16 million; Adjusted EBITDA of over $78 million in Q3 2025 Subscribers grew to almost 2.5 million, up 21% year-over-year in Q3 2025 Narrows full year 2025 revenue guidance to $2.335 billion to $2.355 billion and Adjusted EBITDA guidance to $307 million to $317 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2025, in a shareholder letter that is posted at investors.hims.com. "This quarter we continued to prove that our vision of helping tens of mill
- Hims & Hers to Announce Third Quarter 2025 Financial Results on November 3, 2025Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report third quarter 2025 financial results after the market closes on Monday, November 3, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a missio
- Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial ResultsRevenue of $544.8 million, up 73% year-over-year in Q2 2025 Net income of $42.5 million; Adjusted EBITDA of $82.2 million in Q2 2025 Subscribers grew to over 2.4 million, up 31% year-over-year in Q2 2025 Affirms full year 2025 revenue guidance of $2.3 billion to $2.4 billion and Adjusted EBITDA guidance of $295 million to $335 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the second quarter ended June 30, 2025, in a shareholder letter that is posted at investors.hims.com. "It's never been more clear that we are delivering exactly what millions of people have been waiti
- Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2025 financial results after the market closes on Monday, August 4, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's manageme
- Hims & Hers Health, Inc. Reports First Quarter 2025 Financial ResultsRevenue of $586.0 million, up 111% year-over-year in Q1 2025 Net income of $49.5 million; Adjusted EBITDA of $91.1 million in Q1 2025 Subscribers grew to 2.4 million, up 38% year-over-year in Q1 2025 Affirms full year 2025 revenue guidance of $2.3 billion to $2.4 billion and raises Adjusted EBITDA guidance to a range of $295 million to $335 million Introduces 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2025, in a shareholder letter that is posted at investors.him
- Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 5, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's management team
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial ResultsRevenue of $1.5 billion, up 69% year-over-year in 2024 Net income of $126 million; Adjusted EBITDA of $177 million in 2024 Subscribers grew to 2.2 million, up 45% year-over-year in 2024 Provides Q1 and full year 2025 guidance, with full year 2025 revenue in the range of $2.3 billion to $2.4 billion and Adjusted EBITDA in the range of $270 million to $320 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2024 in a shareholder letter that is posted at investors.hims.com. "2024 was a fantastic year at Hims and Hers as we con
- Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2024 financial results after the market closes on Monday, February 24, 2025. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the c
- Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial ResultsRevenue of $401.6 million, up 77% year-over-year in Q3 2024 Net income of $75.6 million; Adjusted EBITDA of $51.1 million in Q3 2024 Subscribers grew to 2.0 million, up 44% year-over-year in Q3 2024 Raises full year 2024 revenue guidance to a range of $1.460 billion to $1.465 billion and Adjusted EBITDA guidance to a range of $173 million to $178 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the third quarter ended September 30, 2024 in a shareholder letter that is posted at investors.hims.com. "Improving momentum in both the Hims and Hers brands delivered another strong qu
- Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024Hims & Hers Health, Inc. ((", Hims &, Hers", , NYSE:HIMS), the leading health and wellness platform, today announced that it will report third quarter financial results after the market closes on Monday, November 4, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a mission to
- Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial ResultsRevenue of $315.6 million, up 52% year-over-year in Q2 2024 Net income of $13.3 million; Adjusted EBITDA of $39.3 million in Q2 2024 Subscribers grew to 1.9 million, up 43% year-over-year in Q2 2024 Raises full year 2024 revenue guidance to a range of $1.37 billion to $1.40 billion and Adjusted EBITDA guidance to a range of $140 million to $155 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the second quarter ended June 30, 2024 in a shareholder letter that is posted at investors.hims.com. "Our second quarter results mark an acceleration in what was already an incredibl
- Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024Hims & Hers Health, Inc. ("Hims & Hers") (NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter financial results after the market closes on Monday, August 5, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's management tea
- Hims & Hers Health, Inc. Reports First Quarter 2024 Financial ResultsRevenue of $278.2 million, up 46% year-over-year in 2024 Net income of $11.1 million; Adjusted EBITDA of $32.3 million in Q1 2024 Subscribers grew to 1.7 million, up 41% year-over-year in Q1 2024 Raises full year 2024 guidance to a range of $1.20 billion to $1.23 billion and Adjusted EBITDA to a range of $120 million to $135 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today announced financial results for the first quarter ended March 31, 2024 in a shareholder letter that is posted at investors.hims.com. "We are pleased to begin the year with exceptional results and strong momentum throughout the busines
- Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024Hims & Hers Health, Inc. ((", Hims &, Hers, ", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2024 financial results after the market closes on Monday, May 6, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a mission
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsRevenue of $872.0 million, up 65% year-over-year in 2023 Net income of $1.2 million; Adjusted EBITDA profitability of $20.6 million in Q4 2023 Subscribers grew to 1.5 million, up 48% year-over-year in Q4 2023 Provides Q1 and full year 2024 guidance, with full year 2024 revenue in the range of $1.17 billion to $1.20 billion and Adjusted EBITDA in the range of $100 million to $120 million Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE:HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2023 in a shareholder letter that is posted at investors.hims.com. "Our outstanding results in 2
- Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024Hims & Hers Health, Inc. ((", Hims &, Hers", , NYSE:HIMS), the leading health and wellness platform, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Monday, February 26, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of t
- Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 OutlookRevenue of $226.7 million, up 57% year-over-year in Q3 2023 Net loss of $7.6 million; Adjusted EBITDA profitability of $12.3 million in Q3 2023 Subscribers grew to 1.4 million, up 56% year-over-year in Q3 2023 Exited Q3 2023 with over 80% of orders fulfilled via affiliated facilities Raises full year 2023 revenue guidance to a range of $868 million to $873 million and Adjusted EBITDA guidance to a range of $43 million to $46 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today reported financial results for the third quarter ended September 30, 2023. "I am proud of the progress made across several of our
- Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.hims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a missio
- Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 OutlookRevenue of $207.9 million, up 83% year-over-year in Q2 2023 Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million in Q2 2023 Subscribers grew to 1.3 million, up 74% year-over-year in Q2 2023 Raises full year 2023 revenue guidance to a range of $830 million to $850 million and Adjusted EBITDA guidance to a range of $35 million to $40 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today reported financial results for the second quarter ended June 30, 2023. "This quarter marks a significant turning point for Hims & Hers, where step-change progress was made in transforming our company from an
- Hims & Hers to Announce Second Quarter 2023 Financial Results on August 7, 2023Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report second quarter 2023 financial results after the market closes on Monday, August 7, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.forhims.com and will be archived for one year. About Hims & Hers Health, Inc. Hims & Hers is the leading health and wellness platform on a miss
- Hims & Hers Health, Inc. Reports First Quarter 2023 Financial Results and Raises Full Year 2023 OutlookRevenue of $190.8 million, up 88% year-over-year in Q1 2023 Net loss of $10.1 million; Adjusted EBITDA profitability of $6.1 million in Q1 2023 Subscribers grew to over 1.2 million, up 87% year-over-year in Q1 2023 Raises full year 2023 revenue guidance to a range of $810 million to $830 million and Adjusted EBITDA guidance to a range of $25 million to $30 million Hims & Hers Health, Inc. (("Hims &, Hers" or the "Company", NYSE:HIMS), the leading health and wellness platform, today reported financial results for the first quarter ended March 31, 2023. "We are pleased with our outstanding performance in the first quarter, as our ability to deliver more personalized and accessible p
- Hims & Hers to Announce First Quarter 2023 Financial Results on May 8, 2023Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the leading health and wellness platform, today announced that it will report first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.forhims.com and will be archived for one year. Upcoming Conference Participation Hims & Hers also announced that members of the company's managemen
- Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial ResultsFull year 2022 revenue of $526.9 million, up 94% year-over-year Q4 2022 record revenue of $167.2 million, up 97% year-over-year Q4 2022 net loss of $10.9 million and achieves Adjusted EBITDA profitability of $3.9 million Eclipses one million subscribers at year end, up 88% year-over-year Provides Q1 and full year 2023 guidance, with full year 2023 revenue in the range of $735 million to $755 million and Adjusted EBITDA in the range of $20 million to $30 million Introduces 2025 targets of at least $1.2 billion in revenue and $100 million in Adjusted EBITDA Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE:HIMS), the leading health and wellness platform, today reported fin
- Hims & Hers to Announce Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that it will report fourth quarter and full year 2022 financial results after the market closes on Monday, February 27, 2023. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.forhims.com and will be archived for one year. Up
- Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and Raises Full Year 2022 Outlook; Platform Demand and Financial Outperformance Driving Expected Adjusted EBITDA Profitability Beginning in Q4 2022Quarterly revenue of $144.8 million in Q3 2022, up 95% year-over-year Consumer-centric strategy driving third straight quarterly gain of >100k net new subscriptions, ending Q3 2022 with 991,000 subscriptions, up 80% year-over-year Raises full year 2022 revenue guidance to the range of $519 million to $522 million and Adjusted EBITDA guidance to the range of $(20) million to $(18) million Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today reported financial results for the third quarter ended September 30, 2022. "We are pleased to deliver another quarter of
- Hims & Hers to Announce Third Quarter 2022 Earnings on November 7, 2022Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, today announced that it will report third quarter 2022 financial results after the market closes on Monday, November 7, 2022. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296. A live audio webcast will be available at https://investors.forhims.com and will be archived for one year. About Hims & Hers
- Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 OutlookQuarterly revenue of $113.6 million in Q2 2022, up 87% year-over-year Consumer-centric strategy driving second straight quarterly gain of >100k net new subscriptions, ending Q2 2022 with 817,000 subscriptions, up 80% year-over-year Raises full year 2022 revenue guidance to the range of $470 million to $485 million and Adjusted EBITDA guidance to the range of $(27) million to $(20) million Platform demand and financial outperformance driving expected Adjusted EBITDA profitability within the next four quarters Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the trusted consumer-first platform focused on providing modern personalized health and wellness experiences to consumers, tod
- Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its second quarter 2022 financial results on Monday, August 8, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220707005027/en/Hims & Hers CEO Andrew Dudum and representatives from the company ring the closing bell at the New York Stock Exchange on Tuesday, June 14, 2022. (Photo: Business Wire) Conference Call Details The conference call can be accessed by dialing
- Hims & Hers Health, Inc. Reports First Quarter 2022 Financial Results and Raises Full Year 2022 Revenue OutlookQuarterly revenue surpassed the $100 million mark to $101.3 million in Q1 2022, up 94% year-over-year Largest-ever quarterly gain in member subscriptions, increasing 101,000 in the quarter, ending Q1 2022 with 710,000 subscriptions, up 82% year-over-year Raises full year 2022 revenue guidance to the range of $410.0 million to $425.0 million and maintains Adjusted EBITDA guidance in the range of $(30.0) million to $(20.0) million Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides access to related prescription fulfillment, today reported financial results for the first quart
- Hims & Hers Health, Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its first quarter 2022 financial results on Monday, May 9, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference Call Details The conference call can be accessed by dialing +1 (888) 510-2630 for U.S. participants and +1 (646) 960-0137 for international participants, and referencing conference ID #1704296. A live audio webcast will be available online at https://investors.forhims.com/. A replay of the call will be available via webcast for on-demand listening for 12
- Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides First Quarter and Full Year 2022 OutlookExceeded Q4 2021 and full year 2021 revenue and Adjusted EBITDA guidance Full year revenue grew 83% year-over-year to $271.9 million. Q4 2021 revenue increased from Q3 2021 and grew 104% year-over-year to $84.7 million Q4 2021 ending member subscriptions grew 95% year-over-year to 609,000 Provides Q1 and full year 2022 guidance, with full year 2022 revenue in the range of $365 million to $380 million and Adjusted EBITDA in the range of $(30) million to $(20) million Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals and provides access to related prescription fulfillment, today reporte
- Hims & Hers Health, Inc. to Announce Fourth Quarter and 2021 Financial Results and Host Conference Call on February 22, 2022Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its fourth quarter and fiscal year 2021 financial results on Tuesday, February 22, 2022 at 4:00 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T. Conference Call Details The conference call can be accessed by dialing +1 (888) 510-2630 for U.S. participants and +1 (646) 960-0137 for international participants, and referencing conference ID #1704296. A live audio webcast will be available online at https://investors.forhims.com/. A replay of the call will be available via webcast for on-
- Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial ResultsQ3 2021 revenue grows 79% year-over-year to $74.2 million Q3 2021 ending member subscriptions grow 95% year-over-year to 551,000 Exceeds Q3 2021 revenue guidance, raises full year 2021 guidance Hims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the third quarter ending September 30, 2021. "This latest quarter of results shows that our vision to create a new front door to healthcare is resonating," said Andrew Dudum, CEO and co-founder of Hims & Hers. "Not only did we deliver strong revenue growth in Q3, we did so while maintaining customer acquisit
- Hims & Hers Health, Inc. to Announce Third Quarter 2021 Financial Results and Host Conference CallHims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release fiscal third quarter financial results on Wednesday, November 10, 2021 after market close, with a conference call to follow at 5:00 p.m. E.T. Conference Call Details The conference call can be accessed by dialing (833) 900-2256 for U.S. participants and (236) 714-2727 for international participants, and referencing conference ID # 6691217. A live audio webcast will be available online at https://investors.forhims.com/. A replay of the call will be available via webcast for on-demand listening shor
- Hims & Hers Health, Inc. Reports Second Quarter 2021 Financial ResultsQ2 2021 revenue grows 69% year-over-year to $60.7 million Q2 2021 online revenue grows 75% year-over-year to $58.1 million Exceeds Q2 2021 guidance, raises full year 2021 expectations Hims & Hers Health, Inc. ((", Hims &, Hers", , NYSE:HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the second quarter ending June 30, 2021. "This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core categories to the newer mental health services" said Andrew Dudum, CEO and co-founder of Hims & Hers. "We also heavily invested in key
- Hims & Hers Health, Inc. to Announce Second Quarter 2021 Financial Results and Host Conference CallHims & Hers Health, Inc. (("Hims &, Hers", NYSE:HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release fiscal second quarter financial results on Wednesday, August 11, 2021 after market close, with a conference call to follow at 5:00 p.m. E.T. Conference Call Details The conference call can be accessed by dialing (833) 900-2256 for U.S. participants and (236) 714-2727 for international participants, and referencing conference ID # 9972259. A live audio webcast will be available online at https://investors.forhims.com/. A replay of the call will be available via webcast for on-demand listening short